Hill-Rom (HRC) 10-Q 3 Feb 15 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Dec. 31, 2014	Jan. 26, 2015
Document And Entity Information Abstract
Document Type	10-Q
Amendment Flag	FALSE
Document Period End Date	31-Dec-14
Entity Registrant Name	Hill-Rom Holdings, Inc.
Entity Central Index Key	47518
Current Fiscal Year End Date	-21
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		56,506,661

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Income (USD $)	3 Months Ended
In Millions, except Share data in Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Net Revenue
Capital sales	$373.40	$295.50
Rental revenue	91.6	97.9
Total revenue	465	393.4
Cost of Revenue
Cost of goods sold	220.5	171.2
Rental expenses	44.6	45.4
Total cost of revenue	265.1	216.6
Gross Profit	199.9	176.8
Research and development expenses	21.8	16.4
Selling and administrative expenses	155.1	138
Special charges (Note 8)	3.7	1
Operating Profit	19.3	21.4
Interest expense	-3.2	-2
Investment income and other, net	0.9
Income Before Income Taxes	17	19.4
Income tax expense (Note 9)	4.9	6.2
Net Income	$12.10	$13.20
Net income per Common Share - Basic	$0.21	$0.23
Net income per Common Share - Diluted	$0.21	$0.22
Dividends per Common Share	$0.15	$0.14
Average Common Shares Outstanding - Basic (thousands) (Note 10)	57,137	58,230
Average Common Shares Outstanding - Diluted (thousands) (Note 10)	58,154	59,142

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Income (Loss) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Condensed Consolidated Statements of Comprehensive Income (Loss) [Abstract]
Net Income	$12.10	$13.20
Other Comprehensive Income (Loss), net of tax (Note 7):
Available-for-sale securities and currency hedges	-0.4	0.1
Foreign currency translation adjustment	-22.6	5.8
Change in pension and postretirement defined benefit plans	0.9	0.6
Total Other Comprehensive Income (Loss), net of tax	-22.1	6.5
Total Comprehensive Income (Loss)	($10)	$19.70

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Dec. 31, 2014	Sep. 30, 2014
In Millions, unless otherwise specified
Current Assets
Cash and cash equivalents	$113.70	$99.30
Trade accounts receivable, net of allowances (Note 2)	374.9	411
Inventories (Note 2)	171.3	176.2
Deferred income taxes (Notes 1 and 9)	41.5	40.9
Other current assets	54.8	51.9
Total current assets	756.2	779.3
Property, plant and equipment, net (Note 2)	287.4	261.5
Goodwill (Note 4)	395.7	399.8
Software and other intangible assets, net (Note 2)	247.6	261.1
Deferred income taxes (Notes 1 and 9)	22.8	23
Other assets	26.5	27.4
Total Assets	1,736.20	1,752.10
Current Liabilities
Trade accounts payable	100.7	112.7
Short-term borrowings (Note 5)	127.5	126.9
Accrued compensation	62.2	89.2
Accrued product warranties (Note 12)	28	28.4
Other current liabilities	81.2	85.1
Total current liabilities	399.6	442.3
Long-term debt (Note 5)	454.8	364.9
Accrued pension and postretirement benefits (Note 6)	76.3	76.9
Deferred income taxes (Notes 1 and 9)	32.1	31
Other long-term liabilities	31.1	30.5
Total Liabilities	993.9	945.6
Commitments and Contingencies (Note 14)
SHAREHOLDERS' EQUITY
Common Stock (Note 2)	4.4	4.4
Additional paid-in-capital	135.4	134.1
Retained earnings	1,503.20	1,499.80
Accumulated other comprehensive loss (Note 7)	-96.2	-74.1
Treasury stock, at cost (Note 2)	-804.5	-757.7
Total Shareholders' Equity	742.3	806.5
Total Liabilities and Shareholders' Equity	$1,736.20	$1,752.10

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows (USD $)	3 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Operating Activities
Net income	$12.10	$13.20
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	17.3	16.9
Amortization	2.9	4
Acquisition-related intangible asset amortization	8.1	6.9
Provision for deferred income taxes	0.3	-6.6
Gain on disposal of property, equipment leased to others, intangible assets and impairments	-0.3	-0.2
Stock compensation	4.7	3.6
Excess tax benefits from employee stock plans	-1	0.8
Change in working capital excluding cash, current investments, current debt, acquisitions and dispositions:
Trade accounts receivable	36.1	35.5
Inventories	4.3	-2.3
Other current assets	-3.2	3
Trade accounts payable	-16	-9.6
Accrued expenses and other liabilities	-30.6	-26.6
Other, net	-3.7	3.7
Net cash provided by operating activities	31	42.3
Investing Activities
Capital expenditures and purchases of intangible assets	-44.9	-16.8
Proceeds on sale of property and equipment leased to others	0.5	0.5
Payment for acquisition of businesses, net of cash acquired		-1.3
Refund on acquisition of businesses		4.6
Net cash used in investing activities	-44.4	-13
Financing Activities
Net change in short-term debt	-0.7	-0.1
Borrowings on revolving credit facility	95	7
Proceeds from long-term debt		0.6
Payment of long-term debt	-3.8	-2.5
Purchase of noncontrolling interest	-1	-0.7
Payment of cash dividends	-8.6	-7.9
Proceeds from exercise of stock options	4.7	6.5
Proceeds from stock issuance	0.7	0.7
Excess tax benefits from employee stock plans	1	-0.8
Treasury stock acquired	-56.9	-42.1
Net cash provided by (used in) financing activities	30.4	-39.3
Effect of exchange rate changes on cash	-2.6	0.2
Net Cash Flows	14.4	-9.8
Cash and Cash Equivalents
At beginning of period	99.3	127.4
At end of period	$113.70	$117.60

Summary_of_Significant_Account

Summary of Significant Accounting Policies	3 Months Ended
	Dec. 31, 2014
Summary of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	1.  Summary of Significant Accounting Policies
	Basis of Presentation and Principles of Consolidation
	Unless the context otherwise requires, the terms “Hill-Rom,” “we,” “our” and “us” refer to Hill-Rom Holdings, Inc. and our wholly-owned subsidiaries.  The unaudited Condensed Consolidated Financial Statements appearing in this Quarterly Report on Form 10-Q should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in our latest Annual Report on Form 10-K for the fiscal year ended September 30, 2014 (“2014 Form 10-K”) as filed with the United States (“U.S.”) Securities and Exchange Commission.  The September 30, 2014 Condensed Consolidated Balance Sheet was derived from audited Consolidated Financial Statements, but does not include all disclosures required by accounting principles generally accepted in the U.S.  In the opinion of management, the Condensed Consolidated Financial Statements herein include all adjustments, consisting only of normal recurring adjustments, necessary to state fairly the financial position, results of operations and cash flows for the interim periods presented.  Quarterly results are not necessarily indicative of annual results.
	The Condensed Consolidated Financial Statements include the accounts of Hill-Rom and its wholly-owned subsidiaries.  Intercompany accounts and transactions have been eliminated in consolidation.
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires our management to make estimates and assumptions that affect the reported amounts of certain assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the period.  Actual results could differ from those estimates.  Examples of such estimates include our income taxes (Notes 1 and 9), accounts receivable reserves (Note 2), accrued warranties (Note 12), and commitments and contingencies (Note 14), among others.
	Fair Value Measurements
	Fair value measurements are classified and disclosed in one of the following three categories:
		•	Level 1:  Financial instruments with unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets and liabilities.
		•	Level 2:  Financial instruments with observable inputs other than those included in Level 1 such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
		•	Level 3:  Financial instruments with unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Unobservable inputs reflect our own assumptions that market participants would use in pricing the asset or liability (including assumptions about risk). Unobservable inputs shall be developed based on the best information available in the circumstances, which might include our own data.
	We record cash and cash equivalents, as disclosed on our Condensed Consolidated Balance Sheets, as Level 1 instruments and certain other insignificant derivatives and investments as either Level 2 or 3 instruments.  Refer to Note 5 for disclosure of our debt instrument fair values.
	Taxes Collected from Customers and Remitted to Governmental Units
	Taxes assessed by a governmental authority that are directly imposed on a revenue producing transaction between us and our customers, including but not limited to sales taxes, use taxes and value added taxes, are accounted for on a net (excluded from revenue and costs) basis.
	Income Taxes
	We and our eligible domestic subsidiaries file a consolidated U.S. income tax return. Foreign operations file income tax returns in a number of jurisdictions.  Deferred income taxes are computed using an asset and liability approach to reflect the net tax effects of temporary differences between the financial reporting carrying amounts of assets and liabilities and the corresponding income tax amounts. We have a variety of deferred tax assets in numerous tax jurisdictions. These deferred tax assets are subject to periodic assessment as to recoverability.  If it is determined that it is more likely than not that the benefits will not be realized, valuation allowances are recognized. In evaluating whether it is more likely than not that we would recover these deferred tax assets, future taxable income, the reversal of existing temporary differences and tax planning strategies are considered.
	As of December 31, 2014, we had $27.4 million of valuation allowances on deferred tax assets, on a tax-effected basis, primarily related to foreign operating loss carryforwards and other tax attributes. We believe that our estimates for the valuation allowances recorded against deferred tax assets are appropriate based on current facts and circumstances.
	We account for uncertain income tax positions using a threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The difference between the tax benefit recognized in the financial statements for an uncertain income tax position and the tax benefit claimed in the tax return is referred to as an unrecognized tax benefit.
	Recently Issued Accounting Standards
	In May 2014, the FASB issued Accounting Standards Update (“ASU”) 2014-09, “Revenue from Contracts with Customers”, which provides guidance for revenue recognition. The standard's core principle is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. This guidance will be effective for us in the first quarter of fiscal 2018, ending December 31, 2017.  Early adoption is not permitted.  We are currently in the process of evaluating the impact of adoption of this ASU on our Consolidated Financial Statements.
	There have been no significant changes to our assessment of the impact of recently issued accounting standards included in Note 1 of Notes to Consolidated Financial Statements in our 2014 Form 10-K.

Supplementary_Balance_Sheet_In

Supplementary Balance Sheet Information	3 Months Ended
	Dec. 31, 2014
Supplementary Balance Sheet Information [Abstract]
Supplementary Balance Sheet Information	2.  Supplementary Balance Sheet Information
		31-Dec-14		30-Sep-14
	Allowance for possible losses and discounts on trade receivables	$	30	$	31.4
	Inventories:
	Finished products	$	88.8	$	93.5
	Raw materials and work in process		82.5		82.7
	Total inventory	$	171.3	$	176.2
	Accumulated depreciation of property, plant and equipment	$	593.3	$	588.1
	Accumulated amortization of software and other intangible assets	$	291.4	$	283.3
	Preferred stock, without par value:
	Shares authorized		1,000,000		1,000,000
	Shares issued	None		None
	Common stock, without par value:
	Shares authorized		199,000,000		199,000,000
	Shares issued		80,323,912		80,323,912
	Shares outstanding		56,495,427		57,439,911
	Treasury shares		23,828,485		22,884,001

Acquisitions

Acquisitions	3 Months Ended
	Dec. 31, 2014
Acquisitions [Abstract]
Acquisitions	3. Acquisitions
	Trumpf Medical
	On August 1, 2014, we completed the acquisition of Trumpf Medical (“Trumpf”) and funded the transaction with a combination of cash on hand and borrowings under the revolving credit facility.  Trumpf provides a portfolio of well-established operating room (OR) infrastructure products such as surgical tables, surgical lighting, and supply units and expands our product offerings in the surgical suite.
	The purchase price was $229.9 million ($223.6 million net of cash acquired).  The results of Trumpf are included in the Condensed Consolidated Financial Statements since the date of acquisition.
	The following summarizes the fair value of assets acquired and liabilities assumed at the date of the acquisition.  During the first quarter of 2015, we made certain adjustments to the opening balance sheet as of the acquisition date. These results are preliminary and subject to normal true-up provisions in the purchase agreement and other fair value adjustments.
			Amount
	Trade receivables	$	66.3
	Inventory		63.9
	Other current assets		24.3
	Property, plant, and equipment		42.1
	Goodwill		59.0
	Trade name (5-year useful life)		6.7
	Customer relationships (10-year weighted average useful life)		15.8
	Developed technology (8-year weighted average useful life)		17.8
	Other intangibles		4.8
	Other noncurrent assets		0.7
	Deferred tax asset		14.9
	Current liabilities		(72.3	)
	Long term debt		(6.0	)
	Noncurrent liabilities		(8.1	)
	Total purchase price	$	229.9
	Goodwill was allocated entirely to our Surgical and Respiratory Care segment.  The goodwill related to the acquired German operations will be tax deductible while the remaining goodwill will not be deductible for tax purposes.
	On an unaudited proforma basis, as if the Trumpf acquisition had been consummated prior to the earliest date of the financial results presented, our revenue would have been higher by approximately $60 million for the quarter ended December 31, 2013.  As previously disclosed, the impact to net income on an unaudited proforma basis would not have been significant to our financial results for fiscal 2014.  The unaudited pro forma results are based on the Company's historical financial statements and those of the Trumpf business and do not necessarily indicate the results of operations that would have resulted had the acquisition been completed at the beginning of the comparable period presented and are not indicative of the results of operations in future periods.

Goodwill_and_IndefiniteLived_I

Goodwill and Indefinite-Lived Intangible Assets	3 Months Ended
	Dec. 31, 2014
Goodwill and Indefinite-Lived Intangible Assets [Abstract]
Goodwill and Indefinite-Lived Intangible Assets	4.  Goodwill and Indefinite-Lived Intangible Assets
	The following summarizes goodwill activity by reportable segment:
		North America			Surgical and			International			Total
					Respiratory Care
	Balances at September 30, 2014:
	Goodwill	$	390.6		$	333.5		$	148.5		$	872.6
	Accumulated impairment losses		(358.1	)		-			(114.7	)		(472.8	)
	Goodwill, net at September 30, 2014		32.5			333.5			33.8			399.8
	Changes in Goodwill during the period:
	Goodwill related to acquisitions		-			1.7			-			1.7
	Currency translation effect		-			(4.6	)		(1.2	)		(5.8	)
	Balances at December 31, 2014:
	Goodwill		390.6			330.6			147.3			868.5
	Accumulated impairment losses		(358.1	)		-			(114.7	)		(472.8	)
	Goodwill, net at December 31, 2014	$	32.5		$	330.6		$	32.6		$	395.7
	As discussed in Note 3, we recorded an adjustment to goodwill during the first quarter of fiscal 2015 related to the Trumpf acquisition completed during the fourth quarter of fiscal 2014.

Financing_Agreements

Financing Agreements	3 Months Ended
	Dec. 31, 2014
Financing Agreements [Abstract]
Financing Agreements	5.  Financing Agreements
	Total debt consists of the following:
		31-Dec-14		30-Sep-14
	Revolving credit facility	$	360	$	265
	Term loan, current portion		17.5		16.2
	Term loan, long-term portion		155		160
	Unsecured 7.00% debentures due on February 15, 2024		19.4		19.4
	Unsecured 6.75% debentures due on December 15, 2027		29.8		29.8
	Other		0.6		1.4
	Total debt		582.3		491.8
	Less current portion of debt		127.5		126.9
	Total long-term debt	$	454.8	$	364.9
	We have a credit facility that provides for revolving loans of up to $500.0 million, plus a term loan in the aggregate amount of $200.0 million.  The Company may request to increase the revolving loan commitment and the amount of the term loan by up to an additional $250.0 million.  All amounts due under the credit facility mature upon expiration on August 24, 2017.  The related term loan amortizes so that 37.5 percent of the principal will be repaid over the five year term, with the balance due at maturity.  Borrowings under the credit facility and term loan bear interest at variable rates specified therein, that are currently less than 2.0 percent, and the availability of borrowings is subject to our ability at the time of borrowing to meet certain specified conditions, including compliance with covenants contained in the credit agreement governing the facility.  The credit facility contains covenants that, among other matters, require us to maintain a ratio of consolidated indebtedness to consolidated EBITDA (each as defined in the credit agreement) of not more than 3.5:1.0 and a ratio of consolidated EBITDA to interest expense of not less than 3.5:1.0.  As of December 31, 2014, we had outstanding borrowings of $360.0 million and undrawn letters of credit of $5.3 million under the revolving credit facility, leaving $134.7 million of borrowing capacity available.  We are in compliance with all of our debt covenants as of December 31, 2014.
	Unsecured debentures outstanding at December 31, 2014 have fixed rates of interest.  We have deferred gains included in the amounts above from the termination of previous interest rate swap agreements, and those deferred gains amounted to less than $1.0 million at both December 31, 2014 and September 30, 2014.  The deferred gains are being amortized and recognized as a reduction of interest expense over the remaining term of the related debt through 2024, and as a result, the effective interest rates on that debt have been and will continue to be lower than the stated interest rates.
	We have trade finance credit lines and uncommitted letter of credit facilities.  These lines are associated with the normal course of business and we had $40.9 million and $42.4 million of outstanding standby letters of credit as of December 31, 2014 and September 30, 2014.  As of December 31, 2014, $38.3 million relates to one standby letter of credit issued in connection with the Trumpf acquisition to guarantee Trumpf's outstanding debt, which we paid off during the fourth quarter of fiscal 2014.  The expiration date for this letter of credit is January 2015.
	We are exposed to market risk from fluctuations in interest rates.  The Company sometimes manages its exposure to interest rate fluctuations through the use of interest rate swaps (cash flow hedges).  As of December 31, 2014, we had one interest rate swap agreement with a notional amount of $122.5 million to hedge the variability of cash flows associated with a portion of the term loan variable interest rate payments for the period of January 2014 to August 2017.  The interest rate swap has been designated as a cash flow hedge.  The interest rate swap fair value was a $0.1 million liability as of December 31, 2014 and an asset of $0.2 million as of September 30, 2014.  The fair value measurement for our interest rate swap is classified as Level 2, as described in Note 1.
	The fair value of our debt is estimated based on the quoted market prices for the same or similar issues or on the current rates offered to us for debt of the same remaining maturities. The book values of our short-term debt instruments approximate fair value.  The estimated fair values of our long-term unsecured debentures were $56.3 million at December 31, 2014 and $55.5 million at September 30, 2014, and were based on observable inputs such as quoted prices in markets that are not active.  The estimated fair value of our term loan was $171.7 million and $175.2 million based on quoted prices for similar liabilities at December 31, 2014 and September 30, 2014.  The fair value measurements for both our long-term unsecured debentures and our term loan were classified as Level 2, as described in Note 1.

Retirement_and_Postretirement_

Retirement and Postretirement Plans	3 Months Ended
	Dec. 31, 2014
Retirement and Postretirement Plans [Abstract]
Retirement and Postretirement Plans	6.   Retirement and Postretirement Plans
	We sponsor five defined benefit retirement plans: a master defined benefit retirement plan, a nonqualified supplemental executive defined benefit retirement plan and three defined benefit retirement plans covering employees in Germany and France.  Benefits for such plans are based primarily on years of service and the employee's level of compensation during specific periods of employment.  We contribute funds to trusts as necessary to provide for current service and for any unfunded projected future benefit obligation over a reasonable period of time for our funded plans.  All of our plans have an annual measurement date of September 30.  The following table includes the components of net pension expense for our defined benefit plans.
		Quarter Ended December 31
		2014			2013
	Service cost	$	1.4		$	1.2
	Interest cost		3.7			3.6
	Expected return on plan assets		(4.3	)		(4.2	)
	Amortization of unrecognized prior service cost, net		0.1			0.2
	Amortization of net loss		1.4			0.8
	Net pension expense	$	2.3		$	1.6
	We also sponsor a domestic postretirement health care plan that provides health care benefits to qualified retirees and dependents until eligible for Medicare.  Annual costs related to the domestic postretirement health care plan are not significant.
	We have defined contribution savings plans that cover substantially all U.S. employees and certain non-U.S. employees.  The general purpose of these plans is to provide additional financial security during retirement by providing employees with an incentive to make regular savings.  Company contributions to the plans are based on eligibility and employee contributions.  Expense under these plans was $4.2 million and $3.7 million in each of the quarterly periods ended December 31, 2014 and 2013.

Other_Comprehensive_Income

Other Comprehensive Income	3 Months Ended
	Dec. 31, 2014
Other Comprehensive Income [Abstract]
Other Comprehensive Income	7.  Other Comprehensive Income
	The following table represents the changes in accumulated other comprehensive loss by component:
		Quarter Ended December 31, 2014
		Other comprehensive income (loss)															Accumulated other comprehensive loss
		Prior to			Reclassification			Pre-tax			Tax effect			Net of tax			Beginning			Net activity			Ending
		reclassification			from												balance						balance
	Available-for-sale securities	$	(0.6	)	$	-		$	(0.6	)	$	0.2		$	(0.4	)	$	-		$	(0.4	)	$	(0.4	)
	and currency hedges
	Foreign currency translation		(22.6	)		-			(22.6	)		-			(22.6	)		(34.2	)		(22.6	)		(56.8	)
	adjustment
	Change in pension and postretirement		0.1			1.3			1.4			(0.5	)		0.9			(39.9	)		0.9			(39.0	)
	defined benefit plans
	Total	$	(23.1	)	$	1.3		$	(21.8	)	$	(0.3	)	$	(22.1	)	$	(74.1	)	$	(22.1	)	$	(96.2	)
		Quarter Ended December 31, 2013
		Other comprehensive income															Accumulated other comprehensive loss
		Prior to			Reclassification			Pre-tax			Tax effect			Net of tax			Beginning			Net activity			Ending
		reclassification			from												balance						balance
	Available-for-sale securities	$	0.1		$	-		$	0.1		$	-		$	0.1		$	(0.3	)	$	0.1		$	(0.2	)
	and currency hedges
	Foreign currency translation		5.8			-			5.8			-			5.8			(4.6	)		5.8			1.2
	adjustment
	Change in pension and postretirement		0.2			0.8			1			(0.4	)		0.6			(30.8	)		0.6			(30.2	)
	defined benefit plans
	Total	$	6.1		$	0.8		$	6.9		$	(0.4	)	$	6.5		$	(35.7	)	$	6.5		$	(29.2	)
	The following table represents the items reclassified out of accumulated other comprehensive loss and the related tax effects:
		Quarter Ended December 31
		2014									2013
		Amount			Tax effect			Net of tax			Amount			Tax effect			Net of tax
		reclassified									reclassified
	Change in pension and postretirement	$	1.3		$	(0.5	)	$	0.8		$	0.8		$	(0.3	)	$	0.5
	defined benefit plans (a)
	(a)
	Reclassified from accumulated other comprehensive loss into cost of goods sold and selling and administrative expenses. These components are included in the computation of net periodic pension expense.

Special_Charges

Special Charges	3 Months Ended
	Dec. 31, 2014
Special Charges [Abstract]
Special Charges	8.  Special Charges
	During the second quarter of fiscal 2014, we announced a global restructuring program focused on improving our cost structure.  This action included early retirement and reduction in force programs that eliminated over 200 net positions primarily in the U.S., which was substantially completed in fiscal 2014 with cash expenditures continuing during fiscal 2015.  The program is also reducing our European manufacturing capacity and streamlining our global operations by, among other things, executing a back office process transformation program in Europe.  The restructuring in Europe is in process and, for the first quarter of fiscal 2015, has resulted in severance and benefit charges of $2.3 million and other costs of $1.4 million related to legal and professional fees, temporary labor, project management, and other administrative functions.  Since the inception of the global restructuring program through December 31, 2014, we have recognized aggregate special charges of $28.6 million, which are recorded in both fiscal 2014 and 2015.  We expect to incur $15 million to $20 million of additional European restructuring costs through the completion of the program.
	During the first quarter of fiscal 2014, we initiated a plan to improve our cost structure and streamline our organization by offering an early retirement program to certain manufacturing employees in our Batesville, Indiana plant, meeting specific eligibility requirements, and other minor reduction in force actions.  These programs resulted in the elimination of approximately 35 positions and required recognition of a special charge of approximately $1 million for lump sum payments under the program and severance and other benefits provided to other affected employees.  This action was substantially complete by the end of the second quarter of fiscal 2014.
	For all accrued severance and other benefit charges described above, we record restructuring reserves within other current liabilities. The reserve activity for severance and other benefits during fiscal 2015 was as follows:
	Balance at September 30, 2014	$	11.7
	Expenses		2.3
	Cash Payments		(3.5	)
	Reversals		-
	Balance at December 31, 2014	$	10.5

Income_Taxes

Income Taxes	3 Months Ended
	Dec. 31, 2014
Income Taxes [Abstract]
Income Taxes	9.  Income Taxes
	On December 19, 2014, the President signed into law the Tax Increase Prevention Act of 2014 (the Tax Act). The Tax Act retroactively extended the research and development tax credit for one year beginning January 1, 2014 through December 31, 2014.  This credit had previously expired effective December 31, 2013.
	The effective tax rate for the three-month period ended December 31, 2014 was 28.8 percent compared to 32.0 percent for the comparable period in the prior year.  The lower tax rate is due to the recognition of period tax benefits principally related to the retroactive reinstatement of the research and development tax credit in the current year.
	We expect the reinstatement of the research and development tax credit to favorably impact the effective tax rate for fiscal 2015 by nearly $2 million through a combination of a one-time catch-up adjustment from the reinstatement of the credit recorded in our first quarter of fiscal 2015 and the inclusion of the limited current year research credit into the fiscal 2015 effective tax rate.

Earnings_per_Common_Share

Earnings per Common Share	3 Months Ended
	Dec. 31, 2014
Earnings per Common Share [Abstract]
Earnings per Common Share	10.  Earnings per Common Share
	Basic earnings per share is calculated based upon the weighted average number of outstanding common shares for the period, plus the effect of deferred vested shares.  Diluted earnings per share is calculated consistent with the basic earnings per share calculation plus the effect of dilutive unissued common shares related to stock-based employee compensation programs.  For all periods presented, anti-dilutive stock options were excluded from the calculation of diluted earnings per share.  Cumulative treasury stock acquired, less cumulative shares reissued, have been excluded in determining the average number of shares outstanding.
	Earnings per share are calculated as follows (share information in thousands):
		Quarterly Period Ended December 31
		2014		2013
	Net income	$	12.1	$	13.2
	Average shares outstanding - Basic		57,137		58,230
	Add potential effect of exercise of stock options
	and other unvested equity awards		1,017		912
	Average shares outstanding - Diluted		58,154		59,142
	Net income per common share - Basic	$	0.21	$	0.23
	Net income per common share - Diluted	$	0.21	$	0.22
	Shares with anti-dilutive effect excluded from the computation of  Diluted EPS		461		375

Common_Stock

Common Stock	3 Months Ended
	Dec. 31, 2014
Common Stock [Abstract]
Common Stock	11.  Common Stock
	The stock-based compensation cost that was charged against income, net of tax, for all plans was $3.0 million for the quarterly period ended December 31, 2014 and $2.3 million for the comparable prior year period.

Guarantees

Guarantees	3 Months Ended
	Dec. 31, 2014
Guarantees [Abstract]
Guarantees	12.  Guarantees
	We routinely grant limited warranties on our products with respect to defects in material and workmanship.  The terms of these warranties are generally one year, however, certain components and products have substantially longer warranty periods.  We recognize a reserve with respect to these obligations at the time of product sale, with subsequent warranty claims recorded directly against the reserve.  The amount of the warranty reserve is determined based on historical trend experience for the covered products.  For more significant warranty-related matters which might require a broad-based correction, separate reserves are established when such events are identified and the cost of correction can be reasonably estimated.  The existing broad-based corrections do not limit the manufacture, sale or ongoing use of these products.
	A reconciliation of changes in the warranty reserve for the periods covered in this report is as follows:
		Quarter Ended December 31
		2014			2013
	Balance at beginning of period	$	28.4		$	38.1
	Provision for warranties during the period		2.9			4.6
	Warranty reserves acquired		1.1			-
	Warranty claims during the period		(4.4	)		(5.4	)
	Balance at end of period	$	28		$	37.3
	In the normal course of business we enter into various other guarantees and indemnities in our relationships with suppliers, service providers, customers, business partners and others.  Examples of these arrangements would include guarantees of product performance, indemnifications to service providers and indemnifications of our actions to business partners.  These guarantees and indemnifications have not historically had, nor do we expect them to have, a material impact on our financial condition or results of operations, although indemnifications associated with our actions generally have no dollar limitations.
	In conjunction with our acquisition and divestiture activities, we have entered into select guarantees and indemnifications of performance with respect to the fulfillment of commitments under applicable purchase and sale agreements.  With respect to sale transactions, we also routinely enter into non-competition agreements for varying periods of time.  Guarantees and indemnifications with respect to acquisition and divestiture activities, if triggered, could have a materially adverse impact on our financial condition and results of operations.

Segment_Reporting

Segment Reporting	3 Months Ended
	Dec. 31, 2014
Segment Reporting [Abstract]
Segment Reporting	13.  Segment Reporting
	We disclose segment information that is consistent with the way in which management operates and views the business.  Our operating structure contains the following reporting segments:
	North America - sells and rents our patient support and near-patient technologies and services, as well as our clinical workflow solutions, in the U.S. and Canada.
	Surgical and Respiratory Care - sells and rents our surgical and respiratory care products.
	International - sells and rents similar products as our North America segment in regions outside of the U.S. and Canada.
	Our performance under each reportable segment is measured on a divisional income basis before non-allocated operating and administrative costs, acquisition-related intangible asset amortization, impairments, litigation, and special charges.  Divisional income generally represents the division's gross profit less its direct operating costs along with an allocation of manufacturing and distribution costs, research and development and certain corporate functional expenses.
	Non-allocated operating and administrative costs include functional expenses that support the entire organization such as administration, finance, legal and human resources, expenses associated with strategic developments, acquisition-related intangible asset amortization, and other events that are not indicative of operating trends.  We exclude such amounts from divisional income to allow management to evaluate and understand divisional operating trends without the effects of such items.
		Quarter Ended December 31
		2014			2013
	Revenue:
	North America	$	225.2		$	205.5
	Surgical and Respiratory Care		126.3			63.3
	International		113.5			124.6
	Total revenue	$	465		$	393.4
	Divisional income:
	North America	$	38.5		$	28
	Surgical and Respiratory Care		19.4			14.6
	International		2.8			5.5
	Other operating costs:
	Non-allocated operating and administrative costs		37.7			25.7
	Special charges		3.7			1
	Operating profit		19.3			21.4
	Interest expense		(3.2	)		(2.0	)
	Investment income and other, net		0.9			-
	Income before income taxes	$	17		$	19.4

Commitments_and_Contingencies

Commitments and Contingencies	3 Months Ended
	Dec. 31, 2014
Commitments and Contingencies [Abstract]
Commitments and Contingencies	14.  Commitments and Contingencies
	General
	We are subject to various claims and contingencies arising out of the normal course of business, including those relating to governmental investigations and proceedings, commercial transactions, product liability, employee related matters, antitrust, safety, health, taxes, environmental and other matters.  Litigation is subject to many uncertainties and the outcome of individual litigated matters is not predictable with assurance.  It is possible that some litigation matters for which reserves have not been established could be decided unfavorably to us, and that any such unfavorable decisions could have a material adverse effect on our financial condition, results of operations and cash flows.
	We are also involved in other possible claims, including product and general liability, workers' compensation, auto liability and employment related matters. Such claims in the United States have deductibles and self-insured retentions ranging from $25 thousand to $1.0 million per occurrence or per claim, depending upon the type of coverage and policy period. International deductibles and self-insured retentions are lower.  We are also generally self-insured up to certain stop-loss limits for certain employee health benefits, including medical, drug and dental.  Our policy is to estimate reserves based upon a number of factors including known claims, estimated incurred but not reported claims and outside actuarial analysis, which are based on historical information along with certain assumptions about future events. Such estimated reserves are classified as Other Current Liabilities and Other Long-Term Liabilities within the Condensed Consolidated Balance Sheets.
	Universal Hospital Services, Inc. Litigation
	On January 13, 2015, Universal Hospital Services, Inc. filed a complaint against us in the United States District Court for the Western District of Texas.  The plaintiff alleges, among other things, that we engaged in certain customer contracting practices in violation of state and federal antitrust laws.  The plaintiff also has asserted claims for tortuous interference with business relationships. The plaintiff seeks injunctive relief and money damages in an unspecified amount. We believe that the allegations are without merit and intend to defend this matter vigorously.

Subsequent_Events

Subsequent Events	3 Months Ended
	Dec. 31, 2014
Subsequent Events [Abstract]
Subsequent Events	15.  Subsequent Events
	During January 2015, we acquired access to two new technologies in our clinical focus areas of respiratory care and surgical safety and efficiency.  Total investment spending was $7.5 million, along with the potential for an additional investment of up to $2.5 million over time.  These investments were funded with available cash on hand.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Dec. 31, 2014
Summary of Significant Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation
	Unless the context otherwise requires, the terms “Hill-Rom,” “we,” “our” and “us” refer to Hill-Rom Holdings, Inc. and our wholly-owned subsidiaries.  The unaudited Condensed Consolidated Financial Statements appearing in this Quarterly Report on Form 10-Q should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in our latest Annual Report on Form 10-K for the fiscal year ended September 30, 2014 (“2014 Form 10-K”) as filed with the United States (“U.S.”) Securities and Exchange Commission.  The September 30, 2014 Condensed Consolidated Balance Sheet was derived from audited Consolidated Financial Statements, but does not include all disclosures required by accounting principles generally accepted in the U.S.  In the opinion of management, the Condensed Consolidated Financial Statements herein include all adjustments, consisting only of normal recurring adjustments, necessary to state fairly the financial position, results of operations and cash flows for the interim periods presented.  Quarterly results are not necessarily indicative of annual results.
	The Condensed Consolidated Financial Statements include the accounts of Hill-Rom and its wholly-owned subsidiaries.  Intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires our management to make estimates and assumptions that affect the reported amounts of certain assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the period.  Actual results could differ from those estimates.  Examples of such estimates include our income taxes (Notes 1 and 9), accounts receivable reserves (Note 2), accrued warranties (Note 12), and commitments and contingencies (Note 14), among others.
Fair Value Measurements	Fair Value Measurements
	Fair value measurements are classified and disclosed in one of the following three categories:
		•	Level 1:  Financial instruments with unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets and liabilities.
		•	Level 2:  Financial instruments with observable inputs other than those included in Level 1 such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
		•	Level 3:  Financial instruments with unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Unobservable inputs reflect our own assumptions that market participants would use in pricing the asset or liability (including assumptions about risk). Unobservable inputs shall be developed based on the best information available in the circumstances, which might include our own data.
	We record cash and cash equivalents, as disclosed on our Condensed Consolidated Balance Sheets, as Level 1 instruments and certain other insignificant derivatives and investments as either Level 2 or 3 instruments.  Refer to Note 5 for disclosure of our debt instrument fair values.
Taxes Collected from Customers and Remitted to Governmental Units	Taxes Collected from Customers and Remitted to Governmental Units
	Taxes assessed by a governmental authority that are directly imposed on a revenue producing transaction between us and our customers, including but not limited to sales taxes, use taxes and value added taxes, are accounted for on a net (excluded from revenue and costs) basis.
Income Taxes	Income Taxes
	We and our eligible domestic subsidiaries file a consolidated U.S. income tax return. Foreign operations file income tax returns in a number of jurisdictions.  Deferred income taxes are computed using an asset and liability approach to reflect the net tax effects of temporary differences between the financial reporting carrying amounts of assets and liabilities and the corresponding income tax amounts. We have a variety of deferred tax assets in numerous tax jurisdictions. These deferred tax assets are subject to periodic assessment as to recoverability.  If it is determined that it is more likely than not that the benefits will not be realized, valuation allowances are recognized. In evaluating whether it is more likely than not that we would recover these deferred tax assets, future taxable income, the reversal of existing temporary differences and tax planning strategies are considered.
	As of December 31, 2014, we had $27.4 million of valuation allowances on deferred tax assets, on a tax-effected basis, primarily related to foreign operating loss carryforwards and other tax attributes. We believe that our estimates for the valuation allowances recorded against deferred tax assets are appropriate based on current facts and circumstances.
	We account for uncertain income tax positions using a threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The difference between the tax benefit recognized in the financial statements for an uncertain income tax position and the tax benefit claimed in the tax return is referred to as an unrecognized tax benefit.
Recently Issued Accounting Standards	Recently Issued Accounting Standards
	In May 2014, the FASB issued Accounting Standards Update (“ASU”) 2014-09, “Revenue from Contracts with Customers”, which provides guidance for revenue recognition. The standard's core principle is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. This guidance will be effective for us in the first quarter of fiscal 2018, ending December 31, 2017.  Early adoption is not permitted.  We are currently in the process of evaluating the impact of adoption of this ASU on our Consolidated Financial Statements.
	There have been no significant changes to our assessment of the impact of recently issued accounting standards included in Note 1 of Notes to Consolidated Financial Statements in our 2014 Form 10-K.

Supplementary_Balance_Sheet_In1

Supplementary Balance Sheet Information (Tables)	3 Months Ended
	Dec. 31, 2014
Supplementary Balance Sheet Information [Abstract]
Supplementary Balance Sheet Information		31-Dec-14		30-Sep-14
	Allowance for possible losses and discounts on trade receivables	$	30	$	31.4
	Inventories:
	Finished products	$	88.8	$	93.5
	Raw materials and work in process		82.5		82.7
	Total inventory	$	171.3	$	176.2
	Accumulated depreciation of property, plant and equipment	$	593.3	$	588.1
	Accumulated amortization of software and other intangible assets	$	291.4	$	283.3
	Preferred stock, without par value:
	Shares authorized		1,000,000		1,000,000
	Shares issued	None		None
	Common stock, without par value:
	Shares authorized		199,000,000		199,000,000
	Shares issued		80,323,912		80,323,912
	Shares outstanding		56,495,427		57,439,911
	Treasury shares		23,828,485		22,884,001

Acquisitions_Tables

Acquisitions (Tables) (Trumpf Medical [Member])	3 Months Ended
	Dec. 31, 2014
Trumpf Medical [Member]
Business Acquisition [Line Items]
Schedule of Fair Value of the Assets Acquired and Liabilities Assumed	The following summarizes the fair value of assets acquired and liabilities assumed at the date of the acquisition.  During the first quarter of 2015, we made certain adjustments to the opening balance sheet as of the acquisition date. These results are preliminary and subject to normal true-up provisions in the purchase agreement and other fair value adjustments.
			Amount
	Trade receivables	$	66.3
	Inventory		63.9
	Other current assets		24.3
	Property, plant, and equipment		42.1
	Goodwill		59.0
	Trade name (5-year useful life)		6.7
	Customer relationships (10-year weighted average useful life)		15.8
	Developed technology (8-year weighted average useful life)		17.8
	Other intangibles		4.8
	Other noncurrent assets		0.7
	Deferred tax asset		14.9
	Current liabilities		(72.3	)
	Long term debt		(6.0	)
	Noncurrent liabilities		(8.1	)
	Total purchase price	$	229.9

Goodwill_and_IndefiniteLived_I1

Goodwill and Indefinite-Lived Intangible Assets (Tables)	3 Months Ended
	Dec. 31, 2014
Goodwill and Indefinite-Lived Intangible Assets [Abstract]
Schedule of Goodwill Activity
	The following summarizes goodwill activity by reportable segment:
		North America			Surgical and			International			Total
					Respiratory Care
	Balances at September 30, 2014:
	Goodwill	$	390.6		$	333.5		$	148.5		$	872.6
	Accumulated impairment losses		(358.1	)		-			(114.7	)		(472.8	)
	Goodwill, net at September 30, 2014		32.5			333.5			33.8			399.8
	Changes in Goodwill during the period:
	Goodwill related to acquisitions		-			1.7			-			1.7
	Currency translation effect		-			(4.6	)		(1.2	)		(5.8	)
	Balances at December 31, 2014:
	Goodwill		390.6			330.6			147.3			868.5
	Accumulated impairment losses		(358.1	)		-			(114.7	)		(472.8	)
	Goodwill, net at December 31, 2014	$	32.5		$	330.6		$	32.6		$	395.7

Financing_Agreements_Tables

Financing Agreements (Tables)	3 Months Ended
	Dec. 31, 2014
Financing Agreements [Abstract]
Schedule of Total Debt		31-Dec-14		30-Sep-14
	Revolving credit facility	$	360	$	265
	Term loan, current portion		17.5		16.2
	Term loan, long-term portion		155		160
	Unsecured 7.00% debentures due on February 15, 2024		19.4		19.4
	Unsecured 6.75% debentures due on December 15, 2027		29.8		29.8
	Other		0.6		1.4
	Total debt		582.3		491.8
	Less current portion of debt		127.5		126.9
	Total long-term debt	$	454.8	$	364.9

Retirement_and_Postretirement_1

Retirement and Postretirement Plans (Tables)	3 Months Ended
	Dec. 31, 2014
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Schedule of Components of Net Pension Expense		Quarter Ended December 31
		2014			2013
	Service cost	$	1.4		$	1.2
	Interest cost		3.7			3.6
	Expected return on plan assets		(4.3	)		(4.2	)
	Amortization of unrecognized prior service cost, net		0.1			0.2
	Amortization of net loss		1.4			0.8
	Net pension expense	$	2.3		$	1.6

Other_Comprehensive_Income_Tab

Other Comprehensive Income (Tables)	3 Months Ended
	Dec. 31, 2014
Other Comprehensive Income [Abstract]
Schedule of Changes in AOCL by Component		Quarter Ended December 31, 2014
		Other comprehensive income (loss)															Accumulated other comprehensive loss
		Prior to			Reclassification			Pre-tax			Tax effect			Net of tax			Beginning			Net activity			Ending
		reclassification			from												balance						balance
	Available-for-sale securities	$	(0.6	)	$	-		$	(0.6	)	$	0.2		$	(0.4	)	$	-		$	(0.4	)	$	(0.4	)
	and currency hedges
	Foreign currency translation		(22.6	)		-			(22.6	)		-			(22.6	)		(34.2	)		(22.6	)		(56.8	)
	adjustment
	Change in pension and postretirement		0.1			1.3			1.4			(0.5	)		0.9			(39.9	)		0.9			(39.0	)
	defined benefit plans
	Total	$	(23.1	)	$	1.3		$	(21.8	)	$	(0.3	)	$	(22.1	)	$	(74.1	)	$	(22.1	)	$	(96.2	)
		Quarter Ended December 31, 2013
		Other comprehensive income															Accumulated other comprehensive loss
		Prior to			Reclassification			Pre-tax			Tax effect			Net of tax			Beginning			Net activity			Ending
		reclassification			from												balance						balance
	Available-for-sale securities	$	0.1		$	-		$	0.1		$	-		$	0.1		$	(0.3	)	$	0.1		$	(0.2	)
	and currency hedges
	Foreign currency translation		5.8			-			5.8			-			5.8			(4.6	)		5.8			1.2
	adjustment
	Change in pension and postretirement		0.2			0.8			1			(0.4	)		0.6			(30.8	)		0.6			(30.2	)
	defined benefit plans
	Total	$	6.1		$	0.8		$	6.9		$	(0.4	)	$	6.5		$	(35.7	)	$	6.5		$	(29.2	)
Schedule of Items Reclassified out of AOCL		Quarter Ended December 31
		2014									2013
		Amount			Tax effect			Net of tax			Amount			Tax effect			Net of tax
		reclassified									reclassified
	Change in pension and postretirement	$	1.3		$	(0.5	)	$	0.8		$	0.8		$	(0.3	)	$	0.5
	defined benefit plans (a)
	(a)
	Reclassified from accumulated other comprehensive loss into cost of goods sold and selling and administrative expenses. These components are included in the computation of net periodic pension expense.

Special_Charges_Tables

Special Charges (Tables)	3 Months Ended
	Dec. 31, 2014
Special Charges [Abstract]
Restructuring Activity	Balance at September 30, 2014	$	11.7
	Expenses		2.3
	Cash Payments		(3.5	)
	Reversals		-
	Balance at December 31, 2014	$	10.5

Earnings_per_Common_Share_Tabl

Earnings per Common Share (Tables)	3 Months Ended
	Dec. 31, 2014
Earnings per Common Share [Abstract]
Calculated Earnings per Share		Quarterly Period Ended December 31
		2014		2013
	Net income	$	12.1	$	13.2
	Average shares outstanding - Basic		57,137		58,230
	Add potential effect of exercise of stock options
	and other unvested equity awards		1,017		912
	Average shares outstanding - Diluted		58,154		59,142
	Net income per common share - Basic	$	0.21	$	0.23
	Net income per common share - Diluted	$	0.21	$	0.22
	Shares with anti-dilutive effect excluded from the computation of  Diluted EPS		461		375

Guarantees_Tables

Guarantees (Tables)	3 Months Ended
	Dec. 31, 2014
Guarantees [Abstract]
Reconciliation of Changes in the Warranty Reserve		Quarter Ended December 31
		2014			2013
	Balance at beginning of period	$	28.4		$	38.1
	Provision for warranties during the period		2.9			4.6
	Warranty reserves acquired		1.1			-
	Warranty claims during the period		(4.4	)		(5.4	)
	Balance at end of period	$	28		$	37.3

Segment_Reporting_Tables

Segment Reporting (Tables)	3 Months Ended
	Dec. 31, 2014
Segment Reporting [Abstract]
Reconciliation of Segment Information to Consolidated Financial Information		Quarter Ended December 31
		2014			2013
	Revenue:
	North America	$	225.2		$	205.5
	Surgical and Respiratory Care		126.3			63.3
	International		113.5			124.6
	Total revenue	$	465		$	393.4
	Divisional income:
	North America	$	38.5		$	28
	Surgical and Respiratory Care		19.4			14.6
	International		2.8			5.5
	Other operating costs:
	Non-allocated operating and administrative costs		37.7			25.7
	Special charges		3.7			1
	Operating profit		19.3			21.4
	Interest expense		(3.2	)		(2.0	)
	Investment income and other, net		0.9			-
	Income before income taxes	$	17		$	19.4

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Details) (USD $)	Dec. 31, 2014
In Millions, unless otherwise specified
Summary of Significant Accounting Policies [Abstract]
Valuation allowance on deferred tax assets	$27.40

Supplementary_Balance_Sheet_In2

Supplementary Balance Sheet Information (Details) (USD $)	Dec. 31, 2014	Sep. 30, 2014
In Millions, except Share data, unless otherwise specified
Supplementary Balance Sheet Information [Abstract]
Allowance for possible losses and discounts on trade receivables	$30	$31.40
Inventories:
Finished products	88.8	93.5
Raw materials and work in process	82.5	82.7
Total inventory	171.3	176.2
Accumulated depreciation of property, plant and equipment	593.3	588.1
Accumulated amortization of software and other intangible assets	$291.40	$283.30
Preferred stock, without par value:
Par value
Shares authorized	1,000,000	1,000,000
Shares issued	0	0
Common stock, without par value:
Par value
Shares authorized	199,000,000	199,000,000
Shares issued	80,323,912	80,323,912
Shares outstanding	56,495,427	57,439,911
Treasury shares	23,828,485	22,884,001

Acquisitions_Acquisition_of_Tr

Acquisitions (Acquisition of Trumpf Medical) (Details) (USD $)	3 Months Ended		0 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Aug. 01, 2014	Sep. 30, 2014
Business Acquisition [Line Items]
Purchase price of entity, net of cash acquired		$1.30
Fair value of the assets acquired and liabilities assumed:
Goodwill	395.7			399.8
Trumpf Medical [Member]
Business Acquisition [Line Items]
Purchase price of entity			229.9
Purchase price of entity, net of cash acquired			223.6
Fair value of the assets acquired and liabilities assumed:
Trade receivables			66.3
Inventory			63.9
Other current assets			24.3
Property, plant, and equipment			42.1
Goodwill			59
Other intangibles			4.8
Other noncurrent assets			0.7
Deferred tax asset			14.9
Current liabilities			-72.3
Long term debt			-6
Noncurrent liabilities			-8.1
Total purchase price			229.9
Pro Forma Information:
Total revenues		60
Trumpf Medical [Member] | Trade Name [Member]
Fair value of the assets acquired and liabilities assumed:
Intangible assets (Finite Lived)			6.7
Useful lives assigned to intangibles:
Weighted-average useful life	5 years
Trumpf Medical [Member] | Customer Relationships [Member]
Fair value of the assets acquired and liabilities assumed:
Intangible assets (Finite Lived)			15.8
Useful lives assigned to intangibles:
Weighted-average useful life	10 years
Trumpf Medical [Member] | Technology [Member]
Fair value of the assets acquired and liabilities assumed:
Intangible assets (Finite Lived)			$17.80
Useful lives assigned to intangibles:
Weighted-average useful life	8 years

Goodwill_and_IndefiniteLived_I2

Goodwill and Indefinite-Lived Intangible Assets (Schedule of Goodwill Activity) (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014
Goodwill [Line Items]
Goodwill	$868.50	$872.60
Accumulated impairment losses	-472.8	-472.8
Goodwill, net	395.7	399.8
Goodwill related to acquisitions	1.7
Currency translation effect	-5.8
North America Segment [Member]
Goodwill [Line Items]
Goodwill	390.6	390.6
Accumulated impairment losses	-358.1	-358.1
Goodwill, net	32.5	32.5
Goodwill related to acquisitions
Currency translation effect
Surgical and Respiratory Care Segment [Member]
Goodwill [Line Items]
Goodwill	330.6	333.5
Accumulated impairment losses
Goodwill, net	330.6	333.5
Goodwill related to acquisitions	1.7
Currency translation effect	-4.6
International [Member]
Goodwill [Line Items]
Goodwill	147.3	148.5
Accumulated impairment losses	-114.7	-114.7
Goodwill, net	32.6	33.8
Goodwill related to acquisitions
Currency translation effect	($1.20)

Financing_Agreements_Schedule_

Financing Agreements (Schedule of Total Debt) (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014
Long-term Debt, by Current and Noncurrent [Abstract]
Total debt	$582.30	$491.80
Less current portion of debt	127.5	126.9
Total long-term debt	454.8	364.9
Revolving Credit Facility [Member]
Long-term Debt, by Current and Noncurrent [Abstract]
Total debt	360	265
Term Loan [Member]
Long-term Debt, by Current and Noncurrent [Abstract]
Less current portion of debt	17.5	16.2
Total long-term debt	155	160
Unsecured 7.00% Debentures due on February 15, 2024 [Member]
Long-term Debt, by Current and Noncurrent [Abstract]
Total debt	19.4	19.4
Unsecured debenture interest rate	7.00%
Debt instrument, maturity date	15-Feb-24
Unsecured 6.75% Debentures due on December 15, 2027 [Member]
Long-term Debt, by Current and Noncurrent [Abstract]
Total debt	29.8	29.8
Unsecured debenture interest rate	6.75%
Debt instrument, maturity date	15-Dec-27
Other [Member]
Long-term Debt, by Current and Noncurrent [Abstract]
Total debt	$0.60	$1.40

Financing_Agreements_Narrative

Financing Agreements (Narrative) (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014
Debt Instrument [Line Items]
Outstanding letters of credit	$40.90	$42.40
Deferred gains from the termination of previous interest rate swap agreements	1	1
Fair value of unsecured debentures	56.3	55.5
Fair value of term loan	171.7	175.2
Interest Rate Swap [Member]
Debt Instrument [Line Items]
Interest rate swap agreement, notional amount	122.5
Interest rate swap, fair value	-0.1	0.2
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Outstanding letters of credit	5.3
Senior revolving credit facility, maximum borrowing amount	500
Credit facility expiration date	24-Aug-17
Percent of principal to be repaid over term	37.50%
Number of years under revolving credit facility	5 years
Maximum interest rate during period	2.00%
Outstanding borrowings	360
Current borrowing capacity under the facility	134.7
Guarantee of Trumpf Outstanding Debt [Member]
Debt Instrument [Line Items]
Outstanding letters of credit	38.3
Term Loan [Member]
Debt Instrument [Line Items]
Aggregate value of debt	200
Potential Increase to Credit Facility [Member]
Debt Instrument [Line Items]
Senior revolving credit facility, maximum borrowing amount	$250
Maximum [Member]
Debt Instrument [Line Items]
Ratio of consolidated indebtedness to consolidated EBITDA	3.5
Minimum [Member]
Debt Instrument [Line Items]
Interest coverage ratio	3.5

Retirement_and_Postretirement_2

Retirement and Postretirement Plans (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Defined Benefit Plan Disclosure [Line Items]
Defined contribution savings plans expense	$4.20	$3.70
Master Defined Benefit Retirement Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	1.4	1.2
Interest cost	3.7	3.6
Expected return on plan assets	-4.3	-4.2
Amortization of unrecognized prior service cost, net	0.1	0.2
Amortization of net loss	1.4	0.8
Net pension expense	$2.30	$1.60

Other_Comprehensive_Income_Sch

Other Comprehensive Income (Schedule of Changes in AOCL by Component) (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Sep. 30, 2014	Sep. 30, 2013
Other comprehensive income (loss)
Prior to reclassification	($23.10)	$6.10
Reclassification from	1.3	0.8
Pre-tax	-21.8	6.9
Tax effect	-0.3	-0.4
Net of tax	-22.1	6.5
Accumulated other comprehensive loss
Beginning balance	806.5
Net activity	-22.1	6.5
Ending balance	742.3
Available-for-Sale Securities and Currency Hedges [Member]
Other comprehensive income (loss)
Prior to reclassification	-0.6	0.1
Reclassification from
Pre-tax	-0.6	0.1
Tax effect	0.2
Net of tax	-0.4	0.1
Accumulated other comprehensive loss
Beginning balance		-0.3
Net activity	-0.4	0.1
Ending balance	-0.4	-0.2
Foreign Currency Translation Adjustment [Member]
Other comprehensive income (loss)
Prior to reclassification	-22.6	5.8
Reclassification from
Pre-tax	-22.6	5.8
Tax effect
Net of tax	-22.6	5.8
Accumulated other comprehensive loss
Beginning balance	-34.2	-4.6
Net activity	-22.6	5.8
Ending balance	-56.8	1.2
Pension and Postretirement Defined Benefit Plan Items [Member]
Other comprehensive income (loss)
Prior to reclassification	0.1	0.2
Reclassification from	1.3	0.8
Pre-tax	1.4	1
Tax effect	-0.5	-0.4
Net of tax	0.9	0.6
Accumulated other comprehensive loss
Beginning balance	-39.9	-30.8
Net activity	0.9	0.6
Ending balance	-39	-30.2
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated other comprehensive loss
Beginning balance			-74.1	-35.7
Ending balance	($96.20)	($29.20)	($74.10)	($35.70)

Other_Comprehensive_Income_Sch1

Other Comprehensive Income (Schedule of Items Reclassified out of AOCL) (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Amount reclassified	($17)		($19.40)
Tax effect	4.9		6.2
Net of tax	-12.1		-13.2
Pension and Postretirement Defined Benefit Plan Items [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Amount reclassified	1.3	[1]	0.8	[1]
Tax effect	-0.5	[1]	-0.3	[1]
Net of tax	$0.80	[1]	$0.50	[1]
[1]	Reclassified from accumulated other comprehensive loss into cost of goods sold and selling and administrative expenses. These components are included in the computation of net periodic pension expense.

Special_Charges_Narrative_Deta

Special Charges (Narrative) (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Restructuring Cost and Reserve [Line Items]
Special charge	$3.70	$1
Global Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Number of positions planned to be eliminated		200
Aggregate special charges recognized	28.6
Global Restructuring Program [Member] | Employee Termination and Severance [Member]
Restructuring Cost and Reserve [Line Items]
Special charge	2.3
Global Restructuring Program [Member] | Other Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Special charge	1.4
Global Restructuring Program [Member] | Minimum [Member] | Europe [Member]
Restructuring Cost and Reserve [Line Items]
Expected additional costs	15
Global Restructuring Program [Member] | Maximum [Member] | Europe [Member]
Restructuring Cost and Reserve [Line Items]
Expected additional costs	20
Batesville, Indiana Plant Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Special charge		$1
Number of positions eliminated		35

Special_Charges_Schedule_of_Re

Special Charges (Schedule of Restructuring Activity) (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014
Restructuring Reserve [Roll Forward]
Beginning Balance	$11.70
Expenses	2.3
Cash Payments	-3.5
Reversals
Ending Balance	$10.50

Income_Taxes_Details

Income Taxes (Details) (USD $)	3 Months Ended		12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Sep. 30, 2015
Effective tax rate	28.80%	32.00%
Scenario, Forecast [Member]
Favorable impact of tax credit			$2

Earnings_per_Common_Share_Deta

Earnings per Common Share (Details) (USD $)	3 Months Ended
In Millions, except Share data in Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Earnings per Common Share [Abstract]
Net income	$12.10	$13.20
Average shares outstanding - Basic	57,137	58,230
Add potential effect of exercise of stock options and other unvested equity awards	1,017	912
Average shares outstanding - Diluted	58,154	59,142
Net income per common share - Basic	$0.21	$0.23
Net income per common share - Diluted	$0.21	$0.22
Shares with anti-dilutive effect excluded from the computation of Diluted EPS	461	375

Common_Stock_Details

Common Stock (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Common Stock [Abstract]
Stock based compensation cost charged against income, net of tax	$3	$2.30

Guarantees_Details

Guarantees (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Movement in Standard Product Warranty Accrual [Roll Forward]
Balance at beginning of period	$28.40	$38.10
Provision for warranties during the period	2.9	4.6
Warranty reserves acquired	1.1
Warranty claims during the period	-4.4	-5.4
Balance at end of period	$28	$37.30

Segment_Reporting_Details

Segment Reporting (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Segment Reporting Information [Line Items]
Revenue	$465	$393.40
Special charge	3.7	1
Operating profit	19.3	21.4
Interest expense	-3.2	-2
Investment income and other, net	0.9
Income Before Income Taxes	17	19.4
Corporate and Other [Member]
Segment Reporting Information [Line Items]
Operating profit	-37.7	-25.7
Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Special charge	3.7	1
North America Segment [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenue	225.2	205.5
Operating profit	38.5	28
Surgical and Respiratory Care Segment [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenue	126.3	63.3
Operating profit	19.4	14.6
International [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenue	113.5	124.6
Operating profit	$2.80	$5.50

Commitments_and_Contingencies_

Commitments and Contingencies (Details) (Uninsured Risk [Member], USD $)	Dec. 31, 2014
Uninsured Risk [Member]
Loss Contingencies [Line Items]
Deductibles and self-insured retentions, minimum	$25,000
Deductibles and self-insured retentions, maximum	$1,000,000

Subsequent_Events_Details

Subsequent Events (Details) (Subsequent Event [Member], USD $)	1 Months Ended
In Millions, unless otherwise specified	Jan. 31, 2015
Subsequent Event [Member]
Subsequent Event [Line Items]
Investment in technology	$7.50
Amount of potential payments to acquire technology	$2.50